{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:48:52Z","timestamp":1788482932646,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007827","name":"American College of Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007827","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Avera Transplant Institute"},{"name":"Human Genetics Research Institute"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jceh.2019.07.008","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T11:45:22Z","timestamp":1564055122000},"page":"81-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7586-6691","authenticated-orcid":false,"given":"Raseen","family":"Tariq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Page","family":"Axley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3681-7285","authenticated-orcid":false,"given":"Ashwani K.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2019.07.008_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jamapediatrics.2014.2702","article-title":"Nonalcoholic fatty liver disease: a challenge for pediatricians","volume":"169","author":"Nobili","year":"2015","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jceh.2019.07.008_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2019.07.008_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2019.07.008_bib4","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2019.07.008_bib5","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2019.07.008_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2019.07.008_bib7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","article-title":"Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease","volume":"49","author":"Ong","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2019.07.008_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but No other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2019.07.008_bib9","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2019.07.008_bib10","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/ajg.2012.217","volume":"107","author":"Chalasani","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2019.07.008_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jhep.2006.09.005","article-title":"Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease","volume":"45","author":"Targher","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2019.07.008_bib12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.metabol.2012.08.013","article-title":"Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey","volume":"62","author":"Sirota","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2019.07.008_bib13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2008.06.012","article-title":"Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review","volume":"49","author":"Sookoian","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2019.07.008_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.20781","article-title":"Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease","volume":"42","author":"Villanova","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.07.008_bib15","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3748\/wjg.v11.i12.1848","article-title":"Hepatic steatosis is associated with an increased risk of carotid atherosclerosis","volume":"11","author":"Volzke","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2019.07.008_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hep.25593","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery calcification","volume":"56","author":"Kim","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.07.008_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hep.26610","article-title":"Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease","volume":"59","author":"Pacifico","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.07.008_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.07.008_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057183","article-title":"Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes","volume":"8","author":"Targher","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2019.07.008_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.numecd.2014.01.005","article-title":"Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes","volume":"24","author":"Targher","year":"2014","journal-title":"Nutr Metab Cardiovas"},{"key":"10.1016\/j.jceh.2019.07.008_bib21","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.07.008_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7869\/tg.2012.101","article-title":"Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease","volume":"34","author":"Guleria","year":"2013","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jceh.2019.07.008_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2019.07.008_bib24","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2019.07.008_bib25","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.25855","article-title":"Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events","volume":"56","author":"VanWagner","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.07.008_bib26","first-page":"79","article-title":"Frequency of cardiovascular events and effect on survival in liver transplant recipients for cirrhosis due to alcoholic or nonalcoholic steatohepatitis","volume":"14","author":"Piazza","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jceh.2019.07.008_bib27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.07.008_bib28","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.25772","article-title":"Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.07.008_bib29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2019.07.008_bib30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00125-007-0897-4","article-title":"Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative\/laser-treated retinopathy in type 2 diabetic patients","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.jceh.2019.07.008_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.jceh.2019.07.008_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/dc08-1870","article-title":"Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis","volume":"32","author":"Fraser","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2019.07.008_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.jceh.2019.07.008_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.molmed.2015.08.005","article-title":"Emerging liver-kidney interactions in nonalcoholic fatty liver disease","volume":"21","author":"Musso","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jceh.2019.07.008_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.med.60.101107.134820","article-title":"Emerging molecular targets for the treatment of nonalcoholic fatty liver disease","volume":"61","author":"Musso","year":"2010","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jceh.2019.07.008_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MEG.0000000000000531","article-title":"Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals","volume":"28","author":"Choudhary","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2019.07.008_bib37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/TP.0000000000000945","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation in the United States","volume":"100","author":"Singal","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2019.07.008_bib38","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/lt.25367","article-title":"Association of pre-transplant renal function with liver graft and patient survival after liver transplantation in patients with nonalcoholic steatohepatitis","volume":"25","author":"Molnar","year":"2019","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2019.07.008_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MCG.0000000000000818","article-title":"MELD stratified outcomes among recipients with diabetes or hypertension: simultaneous liver kidney versus liver alone","volume":"52","author":"Singal","year":"2018","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2019.07.008_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pop.2009.01.009","article-title":"Comorbidities of obesity","volume":"36","author":"Schelbert","year":"2009","journal-title":"Prim Care"},{"key":"10.1016\/j.jceh.2019.07.008_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12072-015-9615-3","article-title":"Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center","volume":"9","author":"Agrawal","year":"2015","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2019.07.008_bib42","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/hep.20725","article-title":"Chronic liver injury during obstructive sleep apnea","volume":"41","author":"Tanne","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.07.008_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11695-007-9085-3","article-title":"Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective study","volume":"17","author":"Jouet","year":"2007","journal-title":"Obes Surg"},{"key":"10.1016\/j.jceh.2019.07.008_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jhep.2011.04.022","article-title":"Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese","volume":"56","author":"Aron-Wisnewsky","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2019.07.008_bib45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/obr.12020","article-title":"Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis","volume":"14","author":"Musso","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.jceh.2019.07.008_bib46","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s40618-015-0315-6","article-title":"Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?","volume":"38","author":"Targher","year":"2015","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.jceh.2019.07.008_bib47","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jc.2011-3010","article-title":"Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese","volume":"97","author":"Li","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jceh.2019.07.008_bib48","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jceh.2019.07.008_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MCG.0b013e3182688c15","article-title":"The association between metabolic syndrome and colorectal neoplasm systemic review and meta-analysis","volume":"47","author":"Jinjuvadia","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2019.07.008_bib50","first-page":"322","article-title":"Association between nonalcoholic fatty liver disease and colorectal adenoma: a systematic review and meta-analysis","volume":"8","author":"Ding","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jceh.2019.07.008_bib51","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhep.2012.02.027","article-title":"Non-alcoholic fatty liver disease across the spectrum of hypothyroidism","volume":"57","author":"Chung","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2019.07.008_bib52","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.3748\/wjg.v20.i25.8102","article-title":"Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review","volume":"20","author":"Eshraghian","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2019.07.008_bib53","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.3748\/wjg.v20.i39.14172","article-title":"Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"20","author":"Kelley","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2019.07.008_bib54","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.23235","article-title":"Are women with polycystic ovarian syndrome at a high risk of non-alcoholic fatty liver disease; a meta-analysis","volume":"14","author":"Ramezani-Binabaj","year":"2014","journal-title":"Hepat Mon"},{"key":"10.1016\/j.jceh.2019.07.008_bib55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12020-015-0640-8","article-title":"Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?","volume":"51","author":"Targher","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.jceh.2019.07.008_bib56","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11926-006-0065-8","article-title":"Metabolic disorders in patients with psoriasis and psoriatic arthritis","volume":"8","author":"Mallbris","year":"2006","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jceh.2019.07.008_bib57","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaad.2013.10.044","article-title":"Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study","volume":"70","author":"van der Voort","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jceh.2019.07.008_bib58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.07.008_bib59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jhep.2008.09.011","article-title":"Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis","volume":"50","author":"Sorrentino","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2019.07.008_bib60","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1053\/j.gastro.2009.11.013","article-title":"HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"138","author":"Valenti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2019.07.008_bib61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3748\/wjg.v11.i3.393","article-title":"Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations","volume":"11","author":"Duseja","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2019.07.008_bib62","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/hep.27662","article-title":"The impact of phlebotomy in nonalcoholic fatty liver disease: a prospective, randomized, controlled trial","volume":"61","author":"Adams","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.07.008_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/lt.25322","article-title":"Impact of nonmalignant portal vein thrombosis in transplant recipients with nonalcoholic steatohepatitis","volume":"25","author":"Agbim","year":"2019","journal-title":"Liver Transplant"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688319302026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688319302026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:05:39Z","timestamp":1760853939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688319302026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0973688319302026"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2019.07.008","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2019.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}